Leucine Rich Repeat Containing 50 (LRRC50) (N-Term) Peptide
-
- Target See all LRRC50 products
- LRRC50 (Leucine Rich Repeat Containing 50 (LRRC50))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-LRRC50 antibody (Catalog #: ARP53358_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LRRC50 (Leucine Rich Repeat Containing 50 (LRRC50))
- Synonyms
- 4930457P18Rik Peptide, Lrrc50 Peptide, LRRC50 Peptide, CILD13 Peptide, ODA7 Peptide, LLRC50 Peptide, RGD1310542 Peptide, lrrc50 Peptide, zgc:56169 Peptide, dynein, axonemal assembly factor 1 Peptide, dynein axonemal assembly factor 1 Peptide, dynein, axonemal, assembly factor 1 Peptide, Dnaaf1 Peptide, DNAAF1 Peptide, dnaaf1 Peptide
- Background
-
LRRC50 contains 6 LRR (leucine-rich) repeats. It is proposed that LRRC50 to be a novel candidate gene for human cystic kidney disease, involved in regulation of microtubule-based cilia and actin-based brush border microvilli.
Alias Symbols: DKFZp434A119, FLJ25330, ODA7, CILD13, LRRC50
Protein Size: 725 - Molecular Weight
- 80 kDa
- Gene ID
- 123872
- NCBI Accession
- NM_178452, NP_848547
- UniProt
- Q8NEP3
-